Thirdly, the expression of lymphoid enhancer-binding factor 1 (LEF1) and MMP-9 in the high grade glioma group is extremely high, while the expression in the low-grade glioma group is extremely low, and is negatively correlated with the expression of miR-218. The gene discussed is MMP9; the disease is central nervous system cancer.